Skip to main content

News and Media Releases

Media Releases

VIVO CANNABIS ANNOUNCES APPOINTMENT OF VICE PRESIDENT, NAPANEE OPERATIONS

February 11, 2019

VIVO CANNABIS ANNOUNCES CANNABIS OIL SALES LICENSE GRANTED TO WHOLLY-OWNED ABCANN MEDICINALS

February 11, 2019

VIVO CANNABIS ANNOUNCES APPOINTMENT OF DR. RICHA LOVE AS CHIEF MEDICAL OFFICER

January 7, 2019

VIVO CANNABIS™ RETAINS NATIONAL CAPITAL MARKETS TO PROVIDE INVESTOR RELATIONS SERVICES

December 21, 2018

VIVO ANNOUNCES APPOINTMENT OF PRESIDENT, EUROPEAN OPERATIONS

December 18, 2018

CANNA FARMS WINS TOP REVIEWED LICENSED PRODUCER OF THE YEAR AWARD

December 4, 2018

VIVO Cannabis™ Reports Record Revenue for Q3 2018

November 30, 2018

Harvest Medicine Launches Free Medical Cannabis Telemedicine Platform

October 30, 2018

VIVO Announces Initial $5 Million Strategic Investment in National Access Cannabis

October 23, 2018

Harvest Medicine Signs Agreement with Think Research to Improve Coordination of Medical Cannabis Care

October 22, 2018

Harvest Medicine Continues National Expansion with Acquisition of Trauma Healing Centres

October 17, 2018

VIVO AND LOYALIST COLLEGE COLLABORATE ON CANNABIS APPLIED RESEARCH PROJECT

October 5, 2018

VIVO Partners with Pharmascience to Develop Novel Cannabis Products

October 4, 2018

VIVO Announces $5 million Strategic Investment and Supply Agreement with Westleaf

October 3, 2018

VIVO selects Green Hedge as Distribution Partner for Adult-Use Products

September 28, 2018

VIVO Cannabis Inc. Upgrades to the OTCQX Best Market

September 27, 2018

VIVO Completes First New Seasonal Greenhouse

September 26, 2018

Canna Farms Completes First Shipment of Recreational Cannabis

September 25, 2018

VIVO Launches Beacon Medical Website, Covers the Excise Tax and Announces Affiliation with Strainprint

September 24, 2018

VIVO Cannabis Completes Acquisition of Canna Farms

August 31, 2018

VIVO Cannabis Releases Q2 2018 Results and Provides Business Update

August 30, 2018

VIVO Cannabis Selected as a Supplier to Ontario Retail Cannabis Market

August 21, 2018

ABcann Global Announces Company Name Change to VIVO Cannabis™

August 2, 2018

ABcann Introduces Lumina, a Cannabis Brand Focused on Wellness

lumina
August 2, 2018

Analyst Call re Canna Farms acquisition

If your browser doesn't support HTML5 audio. Here is
Analyst Call re Canna Farms acquisition

Aug 01, 2018

ABcann to Acquire Leading B.C. Producer Canna Farms

July 30, 2018

ABcann Launches FIRESIDE, a Premium Line of Recreational Cannabis

July 27, 2018

ABcann Selected as a Supplier to Alberta Retail Cannabis Market

July 5, 2018

Harvest Medicine Surpasses 15,000 Patient Milestone in under 18 Months of Operation

June 19, 2018

ABcann Global Announces Results of Annual General Meeting

June 7, 2018

ABcann Launches Beacon Medical

beacon medical
May 23, 2018

ABcann Provides Business Update

May 3, 2018

Choom™ and ABcann Announce Strategic Investment and Supply Agreement

March 19, 2018

ABCANN ANNOUNCES RESIGNATION OF FOUNDING DIRECTOR KEN CLEMENT

March 16, 2018

ABCANN RETAINS VIRTUE AS AGENCY OF RECORD

March 8, 2018

ABCANN GLOBAL PROVIDES BUSINESS UPDATE

March 6, 2018

ABCANN GLOBAL COMPLETES $70 MILLION BOUGHT DEAL FINANCING AND $4.8 MILLION EXERCISE OF UNDERWRITERS’ OVER-ALLOTMENT OPTION

February 28, 2018

ABCANN GLOBAL CORPORATION ANNOUNCES FILING OF FINAL PROSPECTUS

February 26, 2018

ABCANN COMPLETES ACQUISITION OF HARVEST MEDICINE

February 1, 2018

ABCANN GLOBAL CORPORATION ANNOUNCES $70 MILLION BOUGHT DEAL FINANCING

January 29, 2018

ABCANN GRANTED AUSTRALIAN IMPORT LICENSE

January 18, 2018

ABCANN APPOINTS NEW CHIEF MARKETING OFFICER

January 5, 2018

ABCANN GLOBAL ANNOUNCES RECEIPT OF HEALTH CANADA LICENSE TO PRODUCE CANNABIS OILS

January 2,2018

ABcann Enters into Agreement to Acquire Leading Medical Cannabis Clinic

December 12,2017

ABcann Global Announces Financial Results and Provides Operational Update

November 30,2017

ABcann Global Announces $30 Million Debenture Financing

November 27,2017

ABcann Global Strengthens Board and Executive Team

November 15,2017

ABcann Global Appoints New Independent Chair

October 17,2017

ABcann Global Receives $11.9 Million from Exercise of Warrants

September 18,2017

ABcann Global Appoints Barry Fishman as Chief Executive Officer

September 7,2017

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

August 30, 2017

ABcann Global files Q2 2017 Financial Results and Provides Operational Update

August 30, 2017

Management’s Discussion and Analysis

August 30, 2017

ABcann RELEASES HIGH LEVEL CBD PRODUCT AND LAUNCHES INITIAL OILS STRATEGY

August 28, 2017

ABcann GLOBAL PROVIDES CONSTRUCTION AND EXPANSION UPDATE

July 26, 2017

ABcann GLOBAL ANNOUNCES LISTING ON THE OTCQB MARKETPLACE AND THE FRANKFURT STOCK EXCHANGE

July 12, 2017

ABcann AND CANNABIS WHEATON ANNOUNCE SIGNING OF AGREEMENT FOR FIRST TRANCHE $15 MILLION INVESTMENT

July 10, 2017

ABcann GLOBAL ANNOUNCES INCLUSION ON THE HORIZONS MEDICAL MARIJUANA LIFE SCIENCES ETF

July 5, 2017

ABcann GLOBAL RECRUITS DR. MICHAEL SHANNON AS CHIEF MEDICAL CONSULTANT

June 29, 2017

ABcann GLOBAL EXTENDS RESEARCH AGREEMENT WITH THE UNIVERSITY OF GUELPH

June 26, 2017

ABcann GLOBAL AND CANNABIS WHEATON SIGN INTERIM AGREEMENT FOR CONSTRUCTION OF ADDITIONAL CANNABIS CULTIVATION FACILITY

May 29, 2017

ABcann GLOBAL ANNOUNCES APPOINTMENT OF W. BRETT WILSON TO ADVISORY BOARD

May 3, 2017

PANDA AND ABcann MEDICINALS ANNOUNCE MULTI-STAGE PRODUCT TESTING METHODOLOGY

April 24, 2017

PANDA AND ABcann MEDICINALS ANNOUNCE CONDITIONAL APPROVAL OF QUALIFYING TRANSACTION

March 30, 2017

PANDA AND ABcann MEDICINALS PROVIDE UPDATE ON QUALIFYING TRANSACTION AND ANNOUNCE $8 MILLION BROKERED FINANCING AND $15 MILLION NON-BROKERED FINANCING

March 23, 2017

PANDA ANNOUNCES PROPOSED QUALIFYING TRANSACTION WITH ABcann MEDICINALS INC

December 2, 2016
Read our: Abcann Global Corporation Corporate Governance Policies And Procedures | Code Of Business Conduct | Insider Trading Policy